Profile: Cerapedics, Inc. is a medical device company focusing on the development and commercialization of novel osteobiologic products based on a proprietary small peptide technology, ABM/P-15™. Our P-15™ peptide is the key component in the i-Factor™ family of products, and is ideal for use in the repair of bony voids or defects in orthopedic applications throughout the skeletal system, including spine and trauma. The i-Factor™ bone graft is a bone graft substitute that uses a unique anorganic bone mineral (ABM) and small peptide, P-15™, that acts as an attachment factor for specific integrins in osteogenic cells. This novel mechanism of action enhances the natural bone healing process resulting in safe, predictable bone formation at a fraction of the cost of conventional growth factors. The P-15 mimics the cell-binding domain of type I human collagen and is also responsible for osteogenic cell attachment to type 1 human collagen. This cell-binding initiates the flow of mechanical & chemical information between cells and the extracellular matrix. The natural bone healing that occurs due to this leads to fusion. The i-Factor bone graft stimulates bone growth in the presence of bone forming cells.

FDA Registration Number: 3007155473